HAL-1/12
General Information
DRACP ID DRACP02017
Peptide Name HAL-1/12
Sequence GKWSKILGHLIR
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=43±14 µM | MTT assay | 48 h | 1 |
SW480 | Colon adenocarcinoma | Carcinoma | IC50> 100 µM | MTT assay | 48 h | 1 |
CCRF-CEM | Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia | Leukemia | IC50> 40 µM | MTT assay | 48 h | 1 |
Hemolytic Activity Rat erythrocytes: IC50>200 μM
Normal (non-cancerous) Cytotoxicity HUVEC: IC50> 100 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C66H110N20O14
Absent amino acids ACDEFMNPQTVY
Common amino acids GIKL
Mass 160412
Pl 11.82
Basic residues 4
Acidic residues 0
Hydrophobic residues 5
Net charge 4
Boman Index -1019
Hydrophobicity -11.67
Aliphatic Index 130
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 5500
Absorbance 280nm 500
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22100226
Title Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells
Doi 10.1016/j.peptides.2011.11.002
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available